ALPK1
Alpha-protein kinase 1
Also known as: ALPK1_HUMAN, FLJ22670, KIAA1527, Lak
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96QP1
- Gene
- ALPK1
- Ensembl
- ENSG00000073331
- Chromosome
- 4
- Canonical length
- 1244 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Centrosome,Basal body
OverviewNCBI Gene
This gene encodes an alpha kinase. Mice which were homozygous for disrupted copies of this gene exhibited coordination defects (PMID: 21208416). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
1244 residues, UniProt reviewed canonical sequence.
>Q96QP1|ALPK1
1 MNNQKVVAVL LQECKQVLDQ LLLEAPDVSE EDKSEDQRCR ALLPSELRTL IQEAKEMKWP
61 FVPEKWQYKQ AVGPEDKTNL KDVIGAGLQQ LLASLRASIL ARDCAAAAAI VFLVDRFLYG
121 LDVSGKLLQV AKGLHKLQPA TPIAPQVVIR QARISVNSGK LLKAEYILSS LISNNGATGT
181 WLYRNESDKV LVQSVCIQIR GQILQKLGMW YEAAELIWAS IVGYLALPQP DKKGLSTSLG
241 ILADIFVSMS KNDYEKFKNN PQINLSLLKE FDHHLLSAAE ACKLAAAFSA YTPLFVLTAV
301 NIRGTCLLSY SSSNDCPPEL KNLHLCEAKE AFEIGLLTKR DDEPVTGKQE LHSFVKAAFG
361 LTTVHRRLHG ETGTVHAASQ LCKEAMGKLY NFSTSSRSQD REALSQEVMS VIAQVKEHLQ
421 VQSFSNVDDR SYVPESFECR LDKLILHGQG DFQKILDTYS QHHTSVCEVF ESDCGNNKNE
481 QKDAKTGVCI TALKTEIKNI DTVSTTQEKP HCQRDTGISS SLMGKNVQRE LRRGGRRNWT
541 HSDAFRVSLD QDVETETEPS DYSNGEGAVF NKSLSGSQTS SAWSNLSGFS SSASWEEVNY
601 HVDDRSARKE PGKEHLVDTQ CSTALSEELE NDREGRAMHS LHSQLHDLSL QEPNNDNLEP
661 SQNQPQQQMP LTPFSPHNTP GIFLAPGAGL LEGAPEGIQE VRNMGPRNTS AHSRPSYRSA
721 SWSSDSGRPK NMGTHPSVQK EEAFEIIVEF PETNCDVKDR QGKEQGEEIS ERGAGPTFKA
781 SPSWVDPEGE TAESTEDAPL DFHRVLHNSL GNISMLPCSS FTPNWPVQNP DSRKSGGPVA
841 EQGIDPDAST VDEEGQLLDS MDVPCTNGHG SHRLCILRQP PGQRAETPNS SVSGNILFPV
901 LSEDCTTTEE GNQPGNMLNC SQNSSSSSVW WLKSPAFSSG SSEGDSPWSY LNSSGSSWVS
961 LPGKMRKEIL EARTLQPDDF EKLLAGVRHD WLFQRLENTG VFKPSQLHRA HSALLLKYSK
1021 KSELWTAQET IVYLGDYLTV KKKGRQRNAF WVHHLHQEEI LGRYVGKDYK EQKGLWHHFT
1081 DVERQMTAQH YVTEFNKRLY EQNIPTQIFY IPSTILLILE DKTIKGCISV EPYILGEFVK
1141 LSNNTKVVKT EYKATEYGLA YGHFSYEFSN HRDVVVDLQG WVTGNGKGLI YLTDPQIHSV
1201 DQKVFTTNFG KRGIFYFFNN QHVECNEICH RLSLTRPSME KPCTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALPK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 9.7 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 9.7 nTPM
- spleen: 8.6 nTPM
- skin: 6.5 nTPM
- urinary bladder: 6.2 nTPM
- tonsil: 5.7 nTPM
- kidney: 5.4 nTPM
Single-cell type
- neutrophils: 1,466 nCPM
- neutrophil progenitors: 733 nCPM
- microglia: 206 nCPM
- pituicytes/fscs: 137 nCPM
- hematopoietic stem cells: 126 nCPM
- choroid plexus epithelial cells: 124 nCPM
Immune cell
- neutrophil: 19 nTPM
- intermediate monocyte: 4.7 nTPM
- classical monocyte: 3.7 nTPM
- myeloid DC: 3.7 nTPM
- non-classical monocyte: 2.2 nTPM
- eosinophil: 1.7 nTPM
Brain region
- hippocampal formation: 14 nTPM
- choroid plexus: 12 nTPM
- cerebral cortex: 10 nTPM
- basal ganglia: 9.3 nTPM
- white matter: 9.2 nTPM
- medulla oblongata: 9.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALPK1.
Disease | AllUniProt
Conditions ALPK1 is implicated in, by any mechanism.
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (ROSAH) MIM:614979
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 954 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome
- ALPK1-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- cytoplasmic pattern recognition receptor signaling pathway
- innate immune response
- positive regulation of canonical NF-kappaB signal transduction
Molecular functions
- ATP binding
- monosaccharide binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALPK1 as an antibody target. Whether an autoantibody or antibody against ALPK1 could matter depends on whether native ALPK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALPK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALPK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...